 TRACON Pharmaceuticals has bolstered its board with the appointment of Carol Lam, who was previously senior vice-president and deputy general counsel at chip giant Qualcomm, as a new director. Lam was at Qualcomm for over a decade, dealing with complex tax, antitrust and IP issues in China, as well as matters involving privacy, employment, and antitrust laws in Europe, said biopharma group TRACON. 